{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:23:46Z","timestamp":1786987426842,"version":"build-2736575974"},"reference-count":87,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.cpcardiol.2020.100598","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T19:49:33Z","timestamp":1588535373000},"page":"100598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Renal Sympathetic Denervation: A Comprehensive Review"],"prefix":"10.1016","volume":"46","author":[{"given":"Oluwaseun A.","family":"Akinseye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willis F.","family":"Ralston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lowell L.","family":"Ketron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine R.","family":"Womack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzoma N.","family":"Ibebuogu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2020.100598_bib0001","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2017.10.073","article-title":"Potential US population impact of the 2017 ACC\/AHA high blood pressure guideline","volume":"71","author":"Muntner","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0002","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0003","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.118.12191","article-title":"Prevalence of apparent treatment-resistant hypertension in the united states: Comparison of the 2008 and 2018 american heart association scientific statements on resistant hypertension","volume":"73","author":"Carey","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0004","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.mayocp.2018.12.033","article-title":"Prevalence of apparent treatment-resistant hypertension in the united states according to the 2017 high blood pressure guideline","volume":"94","author":"Patel","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0005","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","article-title":"Incidence and prognosis of resistant hypertension in hypertensive patients","volume":"125","author":"Daugherty","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0006","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0007","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/bmj.39553.670231.25","article-title":"Adherence to prescribed antihypertensive drug treatments: Longitudinal study of electronically compiled dosing histories","volume":"336","author":"Vrijens","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0008","doi-asserted-by":"crossref","first-page":"967","DOI":"10.15585\/mmwr.mm6536e1","article-title":"Vital signs: Disparities in antihypertensive medication nonadherence among medicare part D beneficiaries\u2014United states, 2014","volume":"65","author":"Ritchey","year":"2016","journal-title":"Morb Mortal Weekly Rep"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0009","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/STROKEAHA.108.522193","article-title":"Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention","volume":"40","author":"Kettani","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2796.2009.02084.x","article-title":"Better adherence to antihypertensive agents and risk reduction of chronic heart failure","volume":"266","author":"Perreault","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0011","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2125.2009.03547.x","article-title":"Adherence level of antihypertensive agents in coronary artery disease","volume":"69","author":"Perreault","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0012","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/archinte.1993.00410160029002","article-title":"Recall of recommendations and adherence to advice among patients with chronic medical conditions","volume":"153","author":"Kravitz","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0013","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008731","article-title":"Trends in healthcare expenditures among US adults with hypertension: National estimates, 2003\u20132014","volume":"7","author":"Kirkland","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0014","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ca.21280","article-title":"Micro\u2010anatomy of the renal sympathetic nervous system: A human postmortem histologic study","volume":"25","author":"Atherton","year":"2012","journal-title":"Clin Anat"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2014.03.059","article-title":"Anatomic assessment of sympathetic peri-arterial renal nerves in man","volume":"64","author":"Sakakura","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0016","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/ca.22720","article-title":"The gross anatomy of the renal sympathetic nerves revisited","volume":"29","author":"Mompeo","year":"2016","journal-title":"Clin Anat"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0017","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/ajh\/hpu258","article-title":"Catheter-based radiofrequency renal denervation: Location effects on renal norepinephrine","volume":"28","author":"Henegar","year":"2015","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0018","doi-asserted-by":"crossref","first-page":"R1517","DOI":"10.1152\/ajpregu.2000.279.5.R1517","article-title":"Neural control of the kidney: Functionally specific renal sympathetic nerve fibers","volume":"279","author":"Dibona","year":"2000","journal-title":"Am J Physiol Regul Integr Comparative Physiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0019","doi-asserted-by":"crossref","first-page":"814","DOI":"10.4330\/wjc.v6.i8.814","article-title":"Renal sympathetic nervous system and the effects of denervation on renal arteries","volume":"6","author":"Kannan","year":"2014","journal-title":"World J Cardiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0020","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.1983.245.1.F1","article-title":"Renal nerves in the pathogenesis of hypertension in experimental animals and humans","volume":"245","author":"Katholi","year":"1983","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0021","doi-asserted-by":"crossref","first-page":"H82","DOI":"10.1152\/ajpheart.1986.250.1.H82","article-title":"Sensory denervation of the kidney attenuates renovascular hypertension in the rat","volume":"250","author":"Wyss","year":"1986","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0022","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1161\/01.HYP.11.1.3","article-title":"Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover","volume":"11","author":"Esler","year":"1988","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0023","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMc0904179","article-title":"Renal sympathetic-nerve ablation for uncontrolled hypertension","volume":"361","author":"Schlaich","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0024","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1056\/NEJM194702202360802","article-title":"Results of bilateral supradiaphragmatic splanchnicectomy for arterial hypertension","volume":"236","author":"Peet","year":"1947","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0025","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1001\/jama.1953.03690160001001","article-title":"Splanchnicectomy for essential hypertension: Results in 1,266 cases","volume":"152","author":"Smithwick","year":"1953","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0026","first-page":"1903","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (the symplicity HTN-2 trial): A randomised controlled trial","volume":"376","year":"2010","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0027","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.110.163014","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: Durability of blood pressure reduction out to 24 months","volume":"57","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0028","first-page":"1","article-title":"Endovascular treatment of resistant and uncontrolled hypertension: Therapies on the horizon","volume":"6","author":"Bunte","year":"2013","journal-title":"JACC: Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0029","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study","volume":"373","author":"Krum","year":"2009","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcin.2011.12.011","article-title":"Renal denervation for hypertension","volume":"5","author":"Bertog","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0031","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00392-011-0346-8","article-title":"Catheter-based renal sympathetic denervation: Chronic preclinical evidence for renal artery safety","volume":"100","author":"Rippy","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0032","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s12170-013-0334-9","article-title":"Novel approaches for the treatment of the patient with resistant hypertension: Renal nerve ablation","volume":"7","author":"Gulati","year":"2013","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0033","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1093\/eurheartj\/eht154","article-title":"Expert consensus document from the european society of cardiology on catheter-based renal denervation","volume":"34","author":"Mahfoud","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0034","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0140-6736(13)62192-3","article-title":"Percutaneous renal denervation in patients with treatment-resistant hypertension: Final 3-year report of the symplicity HTN-1 study","volume":"383","author":"Krum","year":"2014","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0035","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/eurheartj\/ehu209","article-title":"Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial","volume":"35","author":"Esler","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0036","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3909\/ricm0755","article-title":"Renal denervation: Past, present, and future","volume":"16","author":"Hannawi","year":"2015","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0037","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/clc.22008","article-title":"Catheter\u2010based renal denervation for resistant hypertension: Rationale and design of the SYMPLICITY HTN\u20103 trial","volume":"35","author":"Kandzari","year":"2012","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0038","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0039","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jacc.2015.01.037","article-title":"12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: The SYMPLICITY HTN-3 trial","volume":"65","author":"Bakris","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/HYPERTENSIONAHA.117.08928","article-title":"Catheter-based renal nerve ablation as a novel hypertension therapy: Lost, and then found, in translation","volume":"71","author":"Osborn","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0041","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/eurheartj\/ehu441","article-title":"Predictors of blood pressure response in the SYMPLICITY HTN-3 trial","volume":"36","author":"Kandzari","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0042","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(14)61942-5","article-title":"Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): A multicentre, open-label, randomised controlled trial","volume":"385","author":"Azizi","year":"2015","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0043","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006196","article-title":"Blood pressure response to main renal artery and combined main renal artery plus branch renal denervation in patients with resistant hypertension","volume":"6","author":"Fengler","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0044","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jacc.2014.07.937","article-title":"Innervation patterns may limit response to endovascular renal denervation","volume":"64","author":"Tzafriri","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ahj.2015.08.021","article-title":"The SPYRAL HTN global clinical trial program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications","volume":"171","author":"Kandzari","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0046","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0140-6736(17)32281-X","article-title":"Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): A randomised, sham-controlled, proof-of-concept trial","volume":"390","author":"Townsend","year":"2017","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0047","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/S0140-6736(18)30951-6","article-title":"Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial","volume":"391","author":"Kandzari","year":"2018","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0048","first-page":"99","article-title":"Percutaneous renal denervation and the second generation EnligHTN system","volume":"62","author":"Chokka","year":"2014","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0049","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1093\/eurheartj\/eht197","article-title":"Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: The EnligHTN I trial","volume":"34","author":"Worthley","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0050","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.atherosclerosis.2017.04.022","article-title":"Safety and performance of the second generation EnligHTN\u2122 renal denervation system in patients with drug-resistant, uncontrolled hypertension","volume":"262","author":"Worthley","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0051","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/jhh.2016.82","article-title":"Bipolar radiofrequency renal denervation with the vessix catheter in patients with resistant hypertension: 2-year results from the REDUCE-HTN trial","volume":"31","author":"Sievert","year":"2017","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0052","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.4244\/EIJY14M12_02","article-title":"Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the OneShot\u2122 ablation system (RAPID) study","volume":"10","author":"Verheye","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0053","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7929706","article-title":"Safety and efficacy of a new renal denervation catheter in hypertensive patients in the absent of antihypertensive medications: A pilot study","volume":"2019","author":"Li","year":"2019","journal-title":"Int J Hypertens"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0054","unstructured":"The australian SHAM controlled clinical trial of renal DeNervation in patients with resistant hypertension (AUSHAM-RDN-01). https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02444442?term=AUSHAM-RDN-01&rank=1. Updated 2015. Accessed February 2, 2020."},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0055","unstructured":"A prospective, multi-centers, randomized, controlled study of assessing the safety and efficacy of sterile irrigated deflectable ablation catheter used in renal artery in primary hypertension. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03511313?term=SYNAPTIC&recrs=a&draw=5&rank=37. Updated 2018. Accessed February 2, 2020."},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0056","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4244\/EIJV8I1A10","article-title":"First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension","volume":"8","author":"Mabin","year":"2012","journal-title":"EuroIntervention"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0057","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ahj.2017.09.006","article-title":"A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs","volume":"195","author":"Mauri","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0058","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1161\/CIRCULATIONAHA.119.040451","article-title":"Six-month results of treatment-blinded medication titration for hypertension control after randomization to endovascular ultrasound renal denervation or a sham procedure in the RADIANCE-HTN SOLO trial","volume":"139","author":"Azizi","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0059","unstructured":"The RADIANCE II pivotal study: A study of the ReCor medical paradise system in stage II hypertension. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03614260?term=RADIANCE+II&rank=1. Updated 2018. Accessed February 2, 2020."},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0060","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/CIRCULATIONAHA.118.037654","article-title":"A three-arm randomized trial of different renal denervation devices and techniques in patients with resistant hypertension (RADIOSOUND-HTN)","volume":"139","author":"Fengler","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0061","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jvir.2018.03.022","article-title":"First-in-man experience with a novel catheter-based renal denervation system of ultrasonic ablation in patients with resistant hypertension","volume":"29","author":"Chernin","year":"2018","journal-title":"J Vasc Interv Radiol"},{"issue":"18 Supplement 1","key":"10.1016\/j.cpcardiol.2020.100598_bib0062","doi-asserted-by":"crossref","first-page":"B20","DOI":"10.1016\/j.jacc.2013.08.794","article-title":"TCT-61 optimized external focused ultrasound for renal sympathetic denervation-wave II trial","volume":"62","author":"Neuzil","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0063","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/HJH.0000000000001584","article-title":"Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension\u2013WAVE IV","volume":"36","author":"Schmieder","year":"2018","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0064","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4244\/EIJV9I1A20","article-title":"Ethanol-mediated perivascular renal sympathetic denervation: Preclinical validation of safety and efficacy in a porcine model","volume":"9","author":"Fischell","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0065","unstructured":"The TARGET BP I clinical trial: A pivotal, multicenter, blinded, sham procedure-controlled trial of renal denervation by the peregrine system\u2122 kit, in subjects with hypertension. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02910414. Updated 2016. Accessed February 2, 2020."},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0066","unstructured":"The TARGET BP OFF-MED trial: A phase 2, multicenter, blinded, sham procedure-controlled trial of renal denervation by the peregrine system kit, in subjects with hypertension, in the absence of antihypertensive medications. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03503773. Updated 2018. Accessed February 2, 2020."},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0067","doi-asserted-by":"crossref","unstructured":"Owens CD, Gasper WJ, Rousselle S, Seward K. Peri-adventitial renal artery delivery of guanethidine monosulfate attenuates renal nerve function: Preclinical experience and implication for resistant hypertension. 2011;58:B120.","DOI":"10.1016\/j.jacc.2011.10.451"},{"issue":"13 Supplement","key":"10.1016\/j.cpcardiol.2020.100598_bib0068","doi-asserted-by":"crossref","first-page":"B84","DOI":"10.1016\/j.jacc.2019.08.124","article-title":"TCT-84 renal denervation with symplicity spyral catheter in the global symplicity registry: Safety and efficacy at 3 years","volume":"74","author":"B\u00f6hm","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"18 Supplement","key":"10.1016\/j.cpcardiol.2020.100598_bib0069","doi-asserted-by":"crossref","first-page":"B308","DOI":"10.1016\/j.jacc.2016.09.791","article-title":"TCT-761 long-term (3-year) safety and effectiveness from the global SYMPLICITY registry of renal denervation in a real world patient population with uncontrolled hypertension","volume":"68","author":"Mahfoud","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0070","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/HYPERTENSIONAHA.113.01985","article-title":"Effects of renal sympathetic denervation on exercise blood pressure, heart rate, and capacity in patients with resistant hypertension","volume":"63","author":"Ewen","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0071","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jacc.2011.05.036","article-title":"Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension","volume":"58","author":"Ukena","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0072","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002293","article-title":"Neuromatous regeneration as a nerve response after catheter-based renal denervation therapy in a large animal model: Immunohistochemical study","volume":"8","author":"Rousselle","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0073","doi-asserted-by":"crossref","first-page":"R806","DOI":"10.1152\/ajpregu.00227.2014","article-title":"Complex reinnervation pattern after unilateral renal denervation in rats","volume":"310","author":"Rodionova","year":"2016","journal-title":"Am J Physiol Regulat Integr Comparative Physiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0074","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/HYPERTENSIONAHA.118.12250","article-title":"Sustained decrease in blood pressure and reduced anatomical and functional reinnervation of renal nerves in hypertensive sheep 30 months after catheter-based renal denervation","volume":"73","author":"Singh","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0075","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/eurheartj\/ehi184","article-title":"Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure","volume":"26","author":"Petersson","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0076","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0735-1097(97)00104-6","article-title":"Effect of beta-blockade on mortality in patients with heart failure: A meta-analysis of randomized clinical trials","volume":"30","author":"Heidenreich","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0077","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2012.09.019","article-title":"First-in-man safety evaluation of renal denervation for chronic systolic heart failure: Primary outcome from REACH-pilot study","volume":"162","author":"Davies","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0078","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jacc.2011.11.034","article-title":"Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension","volume":"59","author":"Brandt","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0079","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jama.2019.21187","article-title":"Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension: The ERADICATE-AF randomized clinical trial","volume":"323","author":"Steinberg","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0080","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1161\/CIRCULATIONAHA.110.991869","article-title":"Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: A pilot study","volume":"123","author":"Mahfoud","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0081","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/HYPERTENSIONAHA.114.04798","article-title":"Denervation of the renal arteries in metabolic syndrome: The DREAMS-study","volume":"65","author":"Verloop","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0082","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/HYPERTENSIONAHA.118.11180","article-title":"Renal denervation in resistant hypertension and obstructive sleep apnea: Randomized proof-of-concept phase II trial","volume":"72","author":"Warchol-Celinska","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0083","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1161\/HYPERTENSIONAHA.111.173799","article-title":"Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea","volume":"58","author":"Witkowski","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0084","first-page":"22","article-title":"Renal denervation reduces pulmonary vascular remodeling and right ventricular diastolic stiffness in experimental pulmonary hypertension","volume":"2","author":"Bos","year":"2017","journal-title":"JACC: Basic Transl Sci"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0085","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/HYPERTENSIONAHA.116.08597","article-title":"Maternal gestational hypertension-induced sensitization of angiotensin II hypertension is reversed by renal denervation or angiotensin-converting enzyme inhibition in rat offspring","volume":"69","author":"Xue","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0086","doi-asserted-by":"crossref","first-page":"700","DOI":"10.4244\/EIJV9I6A114","article-title":"Anxiety, depression, quality of life and stress in patients with resistant hypertension before and after catheter-based renal sympathetic denervation","volume":"9","author":"Lenski","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.cpcardiol.2020.100598_bib0087","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jacc.2012.07.029","article-title":"Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension","volume":"60","author":"Geisler","year":"2012","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014628062030075X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014628062030075X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:27:08Z","timestamp":1758940028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014628062030075X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S014628062030075X"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2020.100598","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal Sympathetic Denervation: A Comprehensive Review","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2020.100598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"100598"}}